Physician profile
Amir Mojaver
NPI 1144434861
$6,781.13
in general payments reported to CMS, 2019-2025
9 companies · $923 in 2025
The $923 reported for 2025 was more than what 95% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,464 · 2020: $2,528 · 2021: $738 · 2022: $927 · 2023: $98.95 · 2024: $102 · 2025: $923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512 · Education: $475 · Gift: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.66 |
| Education | $475.00 |
| Gift | $137.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $3,758.86 | 2019-2022 | |
| Align Technology, INC. | $932.17 | 2020-2025 | Invisalign |
| Patterson Companies, INC. | $879.68 | 2022-2025 | |
| Ultradent Products INC | $430.88 | 2020-2025 | Opalescence |
| Dentsply Sirona INC | $255.46 | 2021-2025 | Cerec, Waveone Gold Conform Fit |
| Biohorizons Implant Systems INC. | $172.15 | 2020-2023 | Biohorizons |
| Orapharma, A Division of Bausch Health US, LLC | $170.94 | 2019-2022 | |
| Biolase, INC. | $165.19 | 2019-2023 | Waterlase Iplus |
| Philips North America LLC | $15.80 | 2024 | (Dn7) Ptb - Premium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Mojaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.